John Schafer

ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada.

Larrea Biosciences Corp. operates as a pharmaceutical company that engages in manufacturing, licensing and distributing green dietary supplements. It sells the products derived from the production of the proprietary extracts from Larrea tridentata plant. The company was founded on May 1, 2002 and is headquartered in Houston, TX.

Part of ULVAC, Inc., Physical Electronics USA, Inc. is a company that manufactures and sells surface analysis equipment. The company is based in Chanhassen, MN.